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Evaluation of glucose challenge and oral glucose tolerance test
results in pregnancy and estimation of prevalence of gestational
diabetes mellitus at Sema Hospital in İstanbul
Ahmet Ruhi TORAMAN1, Ahmet GÜREL2, Zeynep ULUSAL3, Gülnihal BÜLBÜL3,
Ayşe Gülçin DEMİRDÖVEN3, Melek UZUN3, Ali ÖZCAN4, Muzaffer ÇAKMAK5

Aim: This study was designed to evaluate glucose screening and oral glucose tolerance test results, and to assess the
prevalence of gestational diabetes in pregnant patients admitted to our hospital.
Materials and methods: This retrospective study was carried out at Sema Hospital in İstanbul, Turkey. The study
subjects were recruited between January 2006 and August 2009. A glucose challenge test (GCT) was given to 1681
pregnant women and based on the results 494 went on to take an oral glucose tolerance test (OGTT). A diagnosis of
gestational diabetes mellitus (GDM) was made according to the criteria defined by the National Diabetes Data Group.
Results: Out of the 1681 pregnant women tested, 58 were diagnosed with gestational diabetes. Pregnant women with
GDM had GCT results greater than or equal to 145 mg/dL. While the percentage of GCT false positives was 87.8% when
the cut-off value was taken to be 140 mg/dL, it was calculated to be 84.3% when the cut-off value was taken to be 145
mg/dL. For the 140 mg/dL cut-off value of GCT, specificity was 100% and sensitivity was 4.3%, and for the 145 mg/dL
cut-off value of GCT, specificity was 98.3% and sensitivity was 28.3%.
Conclusion: The prevalence value in this study was calculated at 3.45%. Pregnant women diagnosed with GDM had
GCT results higher than 145 mg/dL. When the cut-off value was increased from 140 mg/dL to 145 mg/dL, a decrease
was observed in false positives, and an increase was observed in sensitivity.
Key words: Gestation, gestational diabetes, glucose screening test, oral glucose tolerance test, prevalence

Introduction
Gestational diabetes can be the cause of serious health
problems during the physiologic changes associated
with pregnancy (1). Gestational diabetes mellitus
(GDM) is described as carbohydrate intolerance of
variable severity with onset or first recognition during
pregnancy (2). GDM is not only of clinical relevance,
but is also an important public health issue. The
complications of diabetes that can affect the mother

and fetus are well known. The importance of GDM is
that it is a common complication of pregnancy and
results in a high risk of developing type 2 diabetes
mellitus. The investigations show that maternal
complications include preterm labor, preeclampsia,
nephropathy, birth trauma, cesarean section, and
postoperative wound complications (3). It also causes
different complications in prenatal, natal, or postnatal
periods. It has been suggested that maternal GDM
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increases the offspring’s cardiometabolic risk, and in
utero hyperinsulinemia is an independent predictor of
abnormal glucose tolerance in childhood (4). Studies
by different authors show that fetal complications
include fetal wastage from early pregnancy loss or
congenital anomalies, neonatal hypoglycemia, fetal
macrosomia, shoulder dystocia, stillbirth, growth
restriction, and perinatal death (5,6). Thus, early
detection of GDM in women may prevent or delay
these diseases in mother and baby, thereby improving
their quality of life.
Studies of GDM prevalence is still an important
issue that must not be underestimated. The stepwise
algorithm of the National Diabetes Data Group
(NDDG) is one of the guidelines most widely
accepted for the screening and diagnosis of GDM.
According to this procedure, all pregnant women
without previously diagnosed diabetes are offered
screening for GDM with a 50-g 1-h glucose challenge
test (GCT) administered universally at the gestational
age of 26 weeks (±2 weeks). Patients with a GCT
of 140 mg/dL or higher underwent a 100-g 3-h
diagnostic OGTT (7). The prevalence of GDM, as
reported in different studies, varies between 1% and
14% (8,9). The differences in the prevalence of GDM
reported in these studies are as much due to ethnic
and racial characteristics as to the screening protocols
and diagnostic criteria used by the researchers in
question (10).
The purpose of this study was to investigate the
prevalence of GDM and evaluate the GCT and OGTT
results of pregnant women at a private hospital in
İstanbul.
Materials and methods
Setting
This retrospective study was carried out at Sema
Hospital, a private hospital in İstanbul, Turkey,
which serves a mostly medium- and high-income
population in the southern part of İstanbul. The study
subjects were recruited between January 2006 and
August 2009. The hospital information system used at
our hospital offers the capability of conducting testbased screening and data collection. We conducted
screening based on GCT and OGTT tests utilizing
this capability. Patient name and surname, hospital
1236

identification number, age, and test results were used
as test parameters. Parameters such as gestational
age, number of pregnancies, weight, and height that
were collected and stored as paper document files
were excluded. On the other hand, nonpregnant
patients receiving 50- and 100-g glucose loads were
excluded from the assessment. By screening results
among pregnant women we recruited 1681 GCT
and 494 OGTT recipients. Both GCT and OGTT
recipient patient data were paired. Body mass index
(BMI) values were calculated in the screening test.
Procedures of glucose loading tests
In our hospital, a 50-g GCT was given to the patients
at any time of day, regardless of whether or not they
were fasting, and blood was drawn after 1 h. Each
pregnant woman attending the antenatal clinic was
screened in this way between week 24 and 28 of her
pregnancy. If their plasma glucose on screening was
equal to or greater than 140 mg/dL (7.8 mmol/L),
they were recruited for a standard 3-h OGTT. Patients
were classified as gestationally diabetic if 2 or more
out of 4 plasma glucose concentrations were equal
to or greater than the following values: fasting blood
sugar of 105 mg/dL (5.8 mmol/L); 1st hour level of
190 mg/dL (10.5 mmol/L); 2nd hour level of 165 mg/
dL (9.1 mmol/L); and 3rd hour level of 145 mg/dL (8
mmol/L) (7).
Statistical analysis
Data analysis was performed using SPSS for Windows
14.0. All data were presented as mean ± standard
deviation (SD). Differences in the prevalence of GDM
between groups were analyzed using chi-square tests.
The linear trend in the prevalence of GDM with age
was calculated by logistic regression. Analysis of
variance was performed for comparison of different
groups and Tukey’s honestly significant difference
(HSD) test was used for multiple comparisons. The
differences were considered significant when the
probability was less than 0.05.
Results
The results of the GCT and OGTT screening are
summarized in the Table. Of the 1681 pregnant
women, 526 (31.3%) had a positive result in the
screening test; the OGTT was given to 494 (90.3%)
of these pregnant women. Thirty-two (1.9%) patients
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Table. Characteristics of pregnancies, number of GDM (-) and GDM (+) cases, and prevalence value (mean ± standard deviation) in
the pregnant women studied.

Pregnant

N

Age

GCT (mg/dL)

Parity

BMI (kg/m2)

GDM (-)

GDM(+)

Prevalence

1681

28.3 ± 4.4

125 ± 29

1.6 ± 0.9

25.16 ± 3.12

1623

58

3.45

GCT: glucose challenge test, BDM: body mass index, GDM: gestational diabetes mellitus.

with an abnormal result did not complete the study
protocol for differing reasons and were excluded from
this study. GDM was diagnosed for 58 (11.7%) of the
494 pregnant women. No significant difference was
found for BMI between the GCT-negative and GCTpositive groups and between the GDM-negative and
GDM-positive groups.
Prevalence of GDM
The Table presents prevalence values according to
all pregnant women tested. According to the NDDG
criteria, 58 out of the 1681 pregnant women had GDM
(3.45%). We determined that prevalence increased by
age and it was statistically significant (P < 0.05).
Evaluation of results of GCT
We observed that pregnant women diagnosed with
GDM had first hour glucose values above 145 mg/

dL. The GCT result was above 140 mg/dL in 475 of
the pregnant women. In 58 of them, the OGTT was
positive while in 417 of them it was negative. Therefore,
the false positive rate was 87.8%. The GCT result was
above 145 mg/dL in 370 pregnant women. In 58 of
them, the OGTT was positive while in 312 of them it
was negative. Therefore, the false positive rate in this
group was 84.3%. Additionally, the receiver operating
characteristic (ROC) analysis revealed that the GCT
results showing 140 mg/dL had 100% specificity and
4.4% sensitivity, while the GCT results showing 145
mg/dL had a specificity of 98.3% and a sensitivity of
28.3%. ROC analyses were performed separately for
GCT values of 140 mg/dL and 145 mg/dL, and the
area under the curve was calculated to be 0.767 for the
140 mg/dL value (Figure 1) and 0.779 for the 145 mg/
dL value (Figure 2).
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Figure 1. ROC curve of GCT values for 140 mg/dL (area under
curve: 0.767).
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Figure 2. ROC curve of GCT values for 145 mg/dL (area under
curve: 0.779).
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Discussion
Although studies on GDM prevalence have been
conducted for a long time, they maintain their
validity since no definite ratio can be specified.
Many researchers conduct prevalence studies for
their respective societies and share their results with
fellow researchers. In this context, we conducted a
retrospective study for the period between 2006 and
2009. We determined the GDM prevalence for all
age groups to be 3.45%. Compared to other studies
conducted in Turkey, we observed similar ratios. As
a matter of fact, the prospective study conducted
on 21,531 pregnant women between 2005 and 2007
by Karcaaltincaba et al. (11) reported respective
prevalence orders of 3.17% and 4.48% according to
NDDG and Carpenter and Coustan criteria. On the
other hand, studies conducted in 2 central Anatolian
provinces in Turkey reported prevalences of 3.1%
(12) and 3.3% (13). However, prevalence according to
another study conducted in a northeastern province
in Turkey (Trabzon) returned rather different results
compared to our study and those of other researchers.
In that study, Erem et al. (14) determined prevalence
among all age groups in their own region to be 1.23%,
which is a considerably lower value compared to
other studies. Geographical region, ethnicity (15),
and time are significant factors in prevalence studies
and each have an important effect on prevalence. We
consider ethnicity as a factor affecting the results.
Our study and the one by Erem et al. (14) differ from
each other in terms of both geographical region and
time of study. We assume that these differences had
an effect on prevalence results. As a matter of fact, a
study conducted by Seshiah et al. (16) drew attention
to the increase in prevalence as people migrate from
rural to urban environments. Studies conducted by
some other Indian researchers determined different
prevalence values in different regions of the country
on the same dates (17,18). One of the secondary
factors that differentiate our study from the others
could be the dates they were conducted. The literature
supports this idea because an increase in prevalence
can be observed over the years (19). Meanwhile, a
similar trend can be observed with studies conducted
by the same scientists at different dates. Dietz et
al. (20) reported that a prevalence of 2.9% in 1999
had risen to 3.6% by 2006. Feig et al. (21) declared
that the incidence of gestational diabetes increased
1238

significantly over the 9-year study period, from 3.2%
in 1995 to 3.6% in 2001. Similarly, some authors
(22) reported that the prevalence of GDM among
Kaiser Permanente of Colorado members increased
2-fold from 1994 to 2002 (2.1%–4.1%). Although
the prevalence values we calculated are consistent
with other research results, they appear to be lower
compared to data from current literature. As a matter
of fact, the study by Adegbola and Ajayi (23) reported a
prevalence value of 5.4% for the entire pregnant group
(with and without risk factors). A community-based
prospective study showed the prevalence of GDM to
be 13.9% (17). Another study by Punthumapol and
Tekasakul (24) was conducted to determine GDM
prevalence in the 1st, 2nd, and 3rd trimesters and
in the entire pregnancy period of 2010 pregnant
women. They showed GDM prevalence to be 14.22%,
13.04%, 11.96%, and 13.2%, respectively. On the
other hand, Wei et al. (25) reported a prevalence rate
of 5.078% in a prospective population-based study of
16,286 pregnant women according to the American
Diabetes Association criteria.
GCT is the first step in diagnosing GDM.
Depending on the results, the OGTT is conducted
as a second step, which allows a final diagnosis. The
OGTT is conducted for first hour glucose values
above 140 mg/dL. Recent studies have started a debate
on the value of the 140 mg/dL criterion. Considering
complications, Cheng et al. (26) recommended using
130 mg/dL as the limit value for GCT. However, some
studies have contradicted this. Adegbola and Ajayi
(23) reported that a cut-off level of 140 mg/dL had
higher sensitivity and specificity compared to 130
mg/dL. Some researchers argue that false positive
rates were high for the 140 mg/dL value. As a matter
of fact, Ortega-Gonzalez et al. (27) reported that the
false positive rate decreased significantly if a value of
170 mg/dL was considered as the cut-off value. The
results of a multicenter study on GDM screening
methods conducted by Wu et al. (28) argue that 150
mg/dL could be used as a cut-off value. Punthumapol
and Tekasakul (24), on the other hand, recommended
a cut-off value of 177 mg/dL each trimester for GCT
when used for GDM screening purposes. A study
comparing a 50-g glucose screening test and second
hour postprandial blood sugar values in diagnosing
GDM argued that the false positive rate is high at
140 mg/dL, the value accepted for the 50-g screening
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test. The same study recommended a cut-off value
of at least 182 mg/dL to minimize false positives
(29). In results similar to those from the literature,
in the present study it was observed that the GCT
values among GDM-diagnosed pregnant women
were above 145 mg/dL. In addition, we observed that
when a cut off value of 145 mg/dL was used instead
of 140 mg/dL, the false positive rate was lower. In this
study, a GCT cut-off value of 140 mg/dL gave 100%
specificity and 4.4% sensitivity, while a GCT cut-off
value of 145 mg/dL gave 98% specificity and 28.3%
sensitivity. Therefore, we also think that the cut-off
value should be revised. Although an increase of

approximately 24% was observed in the sensitivity
value, a cut-off value of 145 mg/dL is not ideal.
However, this observation demands support from a
larger database and wider population studies.
As a result, the study presented here shows that
the incidence of GDM in pregnant women in the
population studied was 3.45%. Pregnant women
diagnosed with GDM had GCT results higher than
145 mg/dL. When the cut-off value was increased
from 140 mg/dL to 145 mg/dL, a decrease was
observed in false positives, and an increase was
observed in sensitivity.
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